On October 13, 2014, Jordan Fallis suffered a Spinal Cord Injury (SCI) when he under rotated his dirt bike during an attempted back flip. He was paralyzed from the waist down. Jordan made the life-changing decision to become the first human subject to receive a neuro-spinal scaffolding.
Despite his injuries, Jordan has maintained an optimistic and positive attitude which has been inspiring to many. When patient #2, Jesi Stracham (of a 5 patient clinical trial) reached out to him, he didn’t hesitate to offer support, encouragement, and share his experience with her. They become very close through this experience and are now dating.
Since his accident, Jordan works tirelessly in physical therapy about 4 days/week. Jordan’s effort in physical therapy and the time allowing him to participate so frequently, is credited to his friends, family, and the many investor’s and shareholders of this company conducting these clinical trials, who have contributed so generously. Many of these people donating regularly. With out them, Jordan would not be able to live independently and really focus on his recovery. He will be forever grateful to all who have helped him, not only monetarily, but also with all the good wishes and encouragement he has received. If you wish to make a donation to his gofundme, please visit: http://www.gofundme.com/Jordan-Fallis-PT
Due to the support and donations many have made to the NeuroScaffold Foundation, we were able to assist in purchasing the Wearable Therapy Suit from Axiobionics and we have been able to reimburse some of Jordan’s medical expenses. For those unfamiliar with Wearable Therapy, it is Neuromuscular Electric Stimulation (NMES) and is designed to prevent muscle atrophy or treat muscles that have already atrophied by rebuilding muscle mass. For more information on this visit: http://axiobionics.com
Jordan’s progress has been amazing. The following is from InVivo Therapeutics’s three month update on Jordan:
In the time between implantation and the 3-month post-injury assessment, there were no reported serious adverse events associated with the Neuro-Spinal Scaffold and the subject had progressed from a complete AIS A injury to an incomplete AIS C injury with motor, sensory, bowel, and bladder function improvements. Motor improvement from the pre-surgery assessment to the 3-month visit involved the return of active movement of the hip flexors against gravity (allowing for leg to chest motions) and palpable contractions of the knee extensors. Sensory improvement from the pre-surgery assessment to the 3-month visit involved the bilateral return of sensation to two dermatomes extending down the top of the subject’s legs and the S4-S5 dermatome. In addition, the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam, the Spinal Cord Independence Measure (SCIM III) exam, and additional assessments of bowel and bladder function demonstrated that between hospital discharge and the 3-month visit, the subject has regained bowel function and improved bladder function.
Dr. Theodore said, “I am very pleased with the first subject’s progress since the scaffold was implanted. In my experience, this degree of sensory and motor improvement is unexpected. However, this is only one patient and we do not want to over-interpret the data.”
Mark Perrin, InVivo’s CEO, said, “We are impressed with the first subject’s progress to date since comparable spontaneous recovery occurs infrequently in patients with similar injuries. We look forward to continuing to evaluate the Neuro-Spinal Scaffold in this first subject and the remaining subjects planned for this study.”